Sionna Therapeutics, Inc. (SION) Financials

SION Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 305.0 million 16.8 million
Dec. 31, 2025 326.0 million 19.1 million
Sept. 30, 2025 339.3 million 17.6 million
June 30, 2025 352.0 million 15.6 million

SION Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -21.8 million 6.6 million
Dec. 31, 2025 -16.8 million 3.8 million
Sept. 30, 2025 -15.3 million 3.3 million
June 30, 2025 -18.2 million 2.8 million

SION Net Income

No data available :(

SION Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 216.2 million 7.1 million -
Dec. 31, 2025 235.9 million - 8.7 million
Sept. 30, 2025 248.3 million - 7.8 million
June 30, 2025 262.6 million - 9.2 million

SION Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 44.9 million
Dec. 31, 2025 40.0 million
Sept. 30, 2025 44.5 million
June 30, 2025 44.1 million

SION Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 19.0 million 10.5 million -154000
Dec. 31, 2025 204000 15.2 million 9.9 million -
Sept. 30, 2025 87000 16.0 million 7.2 million -
June 30, 2025 - 15.4 million 6.5 million -

SION Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 154000
Dec. 31, 2025 - 152000
Sept. 30, 2025 - 100000
June 30, 2025 - 147000

SION

Price: $36

52 week price:
13.51
48.45

Earnings Per Share: -1.86 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.6 billion

Links: